Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

554 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel.
Crivellari D, Pagani O, Veronesi A, Lombardi D, Nolè F, Thürlimann B, Hess D, Borner M, Bauer J, Martinelli G, Graffeo R, Sessa C, Goldhirsch A; International Breast Cancer Study Group. Crivellari D, et al. Among authors: lombardi d. Ann Oncol. 2001 Mar;12(3):353-6. doi: 10.1023/a:1011132609055. Ann Oncol. 2001. PMID: 11332148 Free article. Clinical Trial.
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring.
Crivellari D, Lombardi D, Corona G, Massacesi C, Talamini R, Sorio R, Magri MD, Lestuzzi C, Lucenti A, Veronesi A, Toffoli G. Crivellari D, et al. Among authors: lombardi d. Ann Oncol. 2006 May;17(5):807-12. doi: 10.1093/annonc/mdl013. Epub 2006 Feb 23. Ann Oncol. 2006. PMID: 16497825 Free article. Clinical Trial.
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer.
Puglisi F, Cardellino GG, Crivellari D, Di Loreto C, Magri MD, Minisini AM, Mansutti M, Andreetta C, Russo S, Lombardi D, Perin T, Damante G, Veronesi A. Puglisi F, et al. Among authors: lombardi d. Ann Oncol. 2008 Sep;19(9):1541-6. doi: 10.1093/annonc/mdn165. Epub 2008 Apr 25. Ann Oncol. 2008. PMID: 18441329 Free article. Clinical Trial.
Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: a multicentric phase I-II study.
Pagani O, Sessa C, Nolè F, Crivellari D, Lombardi D, Thürlimann B, Hess D, Borner M, Bauer J, Martinelli G, Graffeo R, Zucchetti M, D'Incalci M, Goldhirsch A. Pagani O, et al. Among authors: lombardi d, d incalci m. Ann Oncol. 2000 Aug;11(8):985-91. doi: 10.1023/a:1008392927656. Ann Oncol. 2000. PMID: 11038035 Free article. Clinical Trial.
Breast cancer and pregnancy.
Crivellari D, Lombardi D, Scuderi C, Spazzapan S, Magri MD, Giorda G, Berretta M, Veronesi A. Crivellari D, et al. Among authors: lombardi d. Tumori. 2002 May-Jun;88(3):187-92. doi: 10.1177/030089160208800302. Tumori. 2002. PMID: 12195755 Review.
554 results